In a move aimed at simplifying export procedures and enhancing regulatory efficiency, the Drugs Controller General of India ...

So far, the regulator has two approved CAR-T cell therapies, used to treat certain types of cancers ... as the Indian ...

DCGI directs states to ensure uniform implementation of NDCT Rules on new drugs approval: Gireesh Babu, New Delhi Thursday, February 27, 2025, 08:00 Hrs [IST] The Drugs Controller ...

DCGI has sought post-market surveillance data from the drugmakers of two fixed-dose combination medicines—Imipramine Hydrochloride IP + Diazepam IP tablets used to ease co-morbid anxiety, and ...

DCGI asks manufacturers of two FDCs to submit applications within 3 months: Gireesh Babu, New Delhi Friday, February 28, 2025, 08:00 Hrs [IST] The Drugs Controller General of Indi ...

Pharmexcil urges a review of a new rule for drug exports in India, which requires a product registration certificate from the ...

We never sold the combination in the countries where it's banned. Our exports were done only after getting valid product permissions from the State FDA and required export NOCs,' said Arvind Sharma, ...

We have 10,000 plus manufacturing units, we have 10 lakh of sales outlets, we have 4,000 plus medical devices manufacturing ...

News for Bajaj Healthcare Ltd. Bajaj Healthcare Gets DCGI Nod for Generic Parkinson's Drug Bajaj Healthcare receives DCGI approval to manufacture Pimavanserin, a generic medication for treating ...

The DCGI is part of the Central Drugs Standard Control Organisation (CDSCO) looking after the biopharma industry and responsible for approval of licences for specified categories of drugs ...

CDSCO has given manufacturers a final 3-month deadline to submit required data or face regulatory action, including license ...